Facts About Childhood Cancer
- 1 in 285 children will be diagnosed with cancer
- 43 children per day or 15,780 children per year are expected to be diagnosed with cancer
- More than 95% of childhood cancer survivors will have a significant health related issue by the time they are 45 years of age (2); these health related issues are side-effects of either the cancer or more commonly, the result of its treatment.
- Cancer is the number one cause of death by disease among children
- Since 1980, only three drugs, two used in the treatment of ALL, teniposide (1990)(6) and clofarabine (2004)(7), and Unituxin (dinutuximab), recently approved in March, 2015(7) for use in high risk neuroblastoma, have been approved in the first instance for use in children (and only four additional new drugs have been approved for use by both adults and children)
- Since 1980, fewer than 10 drugs have been developed for use in children with cancer
- The average cost of a stay in a hospital for a child with cancer is $40,000 per stay
- Only 4% of federal government cancer research funding goes to children
Funding A Cure
Our Achievements & Efforts
- 88% of total expenses are directly allocated to program services
- 4-star rated charity by Charity Navigator and a Gold Level by GuideStar for sound fiscal management and received accreditation by the BBB Wise Giving Alliance. These are the highest ratings a nonprofit can receive.
- We were named an exceptional charity by Charity Navigator and received a perfect score (100%) for our financial health, accountability and transparency.
- Donated 1.2 million dollars to the Sunshine Project during the 2016 fiscal year
- Upcoming projects for 2017 through our Sunshine Project initiative will focus on Brain Tumors, Ewing Sarcoma and a drug combination with the promise to treat multiple types of pediatric cancer.
- Clinical Research: Conducting two Phase 1 clinical trials at 20 hospitals nationwide
- Pediatric Total Cancer Care Program: Blood and tissue banking program to further personalized medicine for children
- Translational Research: NPCF laboratory at Moffitt Cancer Center is rapidly evaluating agents for Phase I trials
- Pre-clinical Studies: Funded 8 pre-clinical grants totaling $600,000 to Sunshine Project investigators
Sign-up for our newsletter to stay informed through updates a few times a month.